文献速递中药与中成药合理使用中医内科

黄芩苷调控心血管疾病的机制综述

Regulatory Mechanisms of Baicalin in Cardiovascular Diseases: A Review.
PubMed 文献 · Front Pharmacol · 2020-11-02

本文综述黄芩苷在心血管疾病中的药理特征与调控机制。黄芩苷可改善慢性炎症、免疫失衡、脂代谢紊乱、凋亡及氧化应激,对动脉粥样硬化、高血压、心肌梗死再灌注和心力衰竭发挥有益作用。文章旨在揭示其用于心血管疾病预防和/或治疗的应用前景。

要点

  • 黄芩苷是黄芩主要活性成分之一,在东方国家临床应用已有千年历史。
  • 黄芩苷可改善慢性炎症、免疫失衡、脂代谢紊乱、凋亡和氧化应激。
  • 黄芩苷对动脉粥样硬化、高血压、心梗再灌注和心衰有有益作用。

核心结论

  • 黄芩苷通过改善慢性炎症、免疫失衡、脂代谢紊乱、凋亡和氧化应激,对多种心血管疾病发挥有益作用。

研究设计与样本

  • 本文为综述,系统总结黄芩苷的药理特征及其调控心血管疾病的相关机制。

主要发现

  • 黄芩苷可改善慢性炎症、免疫失衡、脂代谢紊乱、凋亡和氧化应激。
  • 黄芩苷对动脉粥样硬化、高血压、心肌梗死及再灌注、心力衰竭的起始和进展发挥有益作用。

临床怎么用

  • 本综述提示黄芩苷可能用于心血管疾病的预防和/或治疗,但临床决策仍需结合具体证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cardiovascular diseases (CVDs) is the leading cause of high morbidity and mortality worldwide, which emphasizes the urgent necessity to develop new pharmacotherapies. In eastern countries, traditional Chinese medicine Scutellaria baicalensis Georgi has been used clinically for thousands of years. Baicalin is one of the main active ingredients extracted from Chinese herbal medicine S. baicalensis. Emerging evidence has established that baicalin improves chronic inflammation, immune imbalance, disturbances in lipid metabolism, apoptosis and oxidative stress. Thereby it offers beneficial roles against the initiation and progression of CVDs such as atherosclerosis, hypertension, myocardial infarction and reperfusion, and heart failure. In this review, we summarize the pharmacological features and relevant mechanisms by which baicalin regulates CVDs in the hope to reveal its application for CVDs prevention and/or therapy.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Xin L, Gao J, Lin H, et al. Regulatory Mechanisms of Baicalin in Cardiovascular Diseases: A Review. Front Pharmacol. 2020. PMID: 33224035. doi:10.3389/fphar.2020.583200

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。